New findings link cardiovascular disease to POAG
Research

New findings link cardiovascular disease to POAG

Recent study investigates systemic and ocular vascular parameters in OAG vs cardiac surgery patients.
RevOpsis raises $16.5M to advance nAMD tri-specific therapy
Pipeline

RevOpsis raises $16.5M to advance nAMD tri-specific therapy

Seed funding will support IND-enabling clinical studies on the first monotherapy agent to target all three angiogenic pathways.
Verana Health launches real-world data TED module
Research

Verana Health launches real-world data TED module

Dataset includes over 250,000 de-identified patients from the AAO IRIS Registry to advance disease clinical research.
Bausch + Lomb reports statistically significant data on novel dry eye supplement
Products

Bausch + Lomb reports statistically significant data on novel dry eye supplement

Randomized study suggests Blink NutriTears may restore tear film homeostasis by addressing DED’s key root causes.
Phoenix-Micron and ArtiKode collaborate on AI-based ophthalmic imaging
Research

Phoenix-Micron and ArtiKode collaborate on AI-based ophthalmic imaging

Artificial intelligence model is integrated with the MICRON OCT imaging workflow to offer precise analysis, enhanced productivity, and data accuracy.
Registration opens for Eyes on Glaucoma 2024
Events

Registration opens for Eyes on Glaucoma 2024

This year’s largest virtual glaucoma meeting kicks off on June 15, 2024.
Medical coverage rates makes a difference in PDR diagnosis
Research

Medical coverage rates makes a difference in PDR diagnosis

Study finds insurance type correlates to disease severity and increased downstream healthcare utilization.
20/20NOW and Visionix partner on DR telehealth screening
Products

20/20NOW and Visionix partner on DR telehealth screening

Latest addition to the tele-optometry platform will be introduced during the 2024 American Telemedicine Association’s 2024 Nexus Conference and Expo in May.
SalioGen Therapeutics's gene coding therapy targets Stargardt disease
Pipeline

SalioGen Therapeutics's gene coding therapy targets Stargardt disease

One-time, non-viral subretinal injection uses novel Gene Coding technology for gene integration.
GA growth rate linked to imaging biomarkers
Research

GA growth rate linked to imaging biomarkers

New study investigates which multimodal imaging markers are associated with geographic atrophy.
CooperVision and AOA launch The Myopia Collective
Events

CooperVision and AOA launch The Myopia Collective

Optometric initiative seeks to disrupt the current standard of care and educate/advocate for myopia management.
Scientists establish AH protein database for vision loss research
Research

Scientists establish AH protein database for vision loss research

Recent study follows Augusta University investigators as they analyze data from human aqueous humor samples.
Patients uncontrolled with cyclosporine A (CsA 0.05%)
Products

Patients uncontrolled with cyclosporine A (CsA 0.05%)

Learn more about an alternative cyclosporine therapy for dry eye patients.
AAPOS names VP as next president
Events

AAPOS names VP as next president

Sean Donahue, MD, PhD, will assume his new role on July 1, 2024.
Ocuphire enrolls first patient in LYNX-2 phase 3 study for phentolamine
Pipeline

Ocuphire enrolls first patient in LYNX-2 phase 3 study for phentolamine

Trial is evaluating phentolamine ophthalmic solution 0.75% (PS) for decreased VA under low (mesopic) light conditions after keratorefractive surgery.
Artificial vision system offers groundbreaking results for blindness
Products

Artificial vision system offers groundbreaking results for blindness

Multi-institute research team from Illinois Institute of Technology seeks new participants to be implanted with an intracortical visual implant.
Ocular Therapeutix announces executive chairman as new CEO
Business

Ocular Therapeutix announces executive chairman as new CEO

Effective immediately, Pravin U. Dugel, MD, will also take over as president.
Oasis launches SOFT PLUG Extended Duration 180-T Tapered Plug
Products

Oasis launches SOFT PLUG Extended Duration 180-T Tapered Plug

Latest addition to punctal occlusion product line features duration up to 180 days before degradation.
BostonSight adds new immersive training to FitAcademy program
Events

BostonSight adds new immersive training to FitAcademy program

Two new events offer more hands-on training for cornea and contact lens residents as well as the first-ever skills training in Latin America.
CSC may get a protected boost from spironolactone
Research

CSC may get a protected boost from spironolactone

Retrospective study evaluates spironolactone as a possible CSC treatment option.